Bruker Reorganizes, Sees Short-Term Revenue and Targets Per-Share Losses | GenomeWeb

Three days after citing “bottom-line set-backs and expense creep” for a 5 percent reduction in Bruker BioSciences’ workforce, CEO Frank Laukien said on Monday that the company is filling a backlog of orders that missed “getting out the door”— turning into revenues — in the second quarter.

“And that bodes well for the future,” Laukien told analysts and investors at the Bear Stearns Healthcare Conference in New York.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: genetic study of breast cancer in Egyptian families, mutations linked to cleft lip and palate, and more.

Council Bluffs, Iowa, schools are encouraging more girls to pursue STEM courses, according to the Associated Press.

Because of new open-access requirements, Gates Foundation-funded researchers can't publish in some top journals, Nature News reports.

In Science this week: deletion of one microRNA allows pluripotent stem cells to form embryonic and non-embryonic lineages, and more.